Table of Contents

1: Agents.- 1. Alkylating and Platinating Agents.- 2. Antimetabolic Agents.- 3. Biologic Agents.- 4. Hormonal Agents.- 5. Tubulin-Targeting Drugs.- 2: Specific Neoplasms and Therapeutic Protocols.- 6. Breast Cancer.- 7. Upper Gastrointestinal Cancer.- 8. Lower Gastrointestinal Cancer.- 9. Head and Neck Cancer.- 10. Lung Cancer.- 11. Melanoma and Other Tumors of the Skin.- 12. Sarcomas.- 13. Genitourinary Cancer.- 14. Gynecologic Malignancies.- 15. Malignant Glioma.- 16. Endocrine Cancer.- 17. Leukemia.- 18. Hodgkin’s Disease.- 19. Non-Hodgkin’s Lymphoma.- 20. Myeloma.- 21. Malignant Effusions in the Chest.- 22. Carcinoma of Unknown Primary.- 23. Aids-Related Malignancies.- 3: Supportive Care.- 24. Palliative Care.- 25. Myelosuppression.- 26. Gastrointestinal Toxicities.- 27. Renal and Metabolic Complications.- 28. Pulmonary and Cardiovascular Complications of Cancer Therapy.- 29. Neurotoxicities.- 30. Evaluation of Quality of Life in Cancer Clinical Trials.- 31. Systemic Manifestations of Cancer and Management of Systemic Paraneoplastic Syndromes.- 32. Malnutrition.- 4: Clinical Trial Data Collection.- 33. Clinical Trials: Monitoring and Reporting of Toxicities, and Evaluating Tumor Response.- 34. Synoptic Pathology Reports.

Promotional Information

Springer Book Archives

About the Author

John W. Kirkwood, MD – Professor and Chief, Division of Medical Oncology, UPitt School of Medicine – Pittsburgh, PA